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bstract
A 43-year-old male and a 39-year-old male presented with multiple pituitary adenomas with two dis-
tinct histological types. The first patient who had multiple endocrine neoplasia type I had developed
acromegaly due to a growth hormone-releasing hormone (GHRH)-producing pancreatic tumor. Both
plasma GHRH and growth hormone (GH) levels decreased to normal after resection of the pancreatic
tumor. However, the plasma GH level gradually increased again and magnetic resonance imaging re-
vealed pituitary adenoma formation. Histological examination revealed two different histological
types of pituitary adenoma: GH cell adenoma and null cell adenoma. The second patient, with no such
genetic condition, had a non-functioning pituitary adenoma. Histological examination revealed two
different histological types of silent GH cell adenoma and silent gonadotroph adenoma. Careful his-
tological examination is required to exclude the possibility of multiple pituitary adenomas.
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Introduction
Pituitary adenomas with multiple histological types
have rarely been discussed. The fragmentation of
specimens of adenoma tissue obtained by the trans-
sphenoidal approach may make accurate diagnosis
of multiplicity more difficult. Therefore, the actual
incidence of double pituitary adenomas in surgical
material is unknown. However, almost all pituitary
adenomas are solitary tumors with a histologically
uniform pattern6'8) including plurihormonal adeno-
ma.5'12'r6) Therefore, accurate histological diagnosis
of pituitary adenoma is considered possible even
based on small tumor fragments. Accurate histologi-
cal diagnosis of plurihormonal pituitary adenomas is
also possible based on tumor fragments.3-5'7'16'18) Mul-
tiple pituitary adenoma is usually detected at au-
topsy,2'e'rt'13'14't7) with an incidence of 8.9o/o in one
large series.e) When adenoma fragments showed dis-
similar histological and immunohistochemical fea-
tures, two different types of adenomas can be recog-
nized.lo)
Here we describe two cases of histologically dou-
ble pituitary adenoma and discuss the combinations
of immunohistochemical subtypes.
Case Reports
Case 1: A 43-year-old male was admitted to our
hospital with increased pituitary mass and an elevat-
ed plasma growth hormone (GH) level in September
1992. His past history was notable for multiple endo-
crine neoplasia (MEN) type l. He was found to have
primary hyperparathyroidism when aged 3l years.
Parathyroidectomy was performed three times be-
tween 3l and 34 years to control hypercalcemia
caused by primary hyperparathyroidism. Thereafter,
he developed acromegalic features. Abdominal com-
puted tomography disclosed a tumor mass in the
tail of the pancreas. Hormonal examination re-
vealed elevated plasm GH-releasing hormone (GH-
RH) level, suggesting that the pancreatic mass wasReceived February 8, 1996; Accepted June I l, 1996
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Fig。1 Case 1. Changes in serum hormone levels
showing normalization of serum GH level af-
ter pancreatic tumor excision but subsequent
reincrease. solid line: GHRH, dotted line:
GH.
Fig. 2 Case l. Serial MR images, 3 months (A), I
year (B), 2 years (C), and 4 years (D) after
pancreatic tumor excision, showing the pitui-
tary gland gradually increased in size suggest-
ing GH cell adenoma formation.
an ectopic GHRH-secreting tumor. Laparotomy was
performed for removal of the pancreatic tumor.
Immunohistochemical staining of the specimen of
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Fig. 3 Case 1. Photomicrographs of the pituitary
adenoma specimen. A: The border (arrows)
between the GH cell adenoma (upper) and the
null cell adenoma (lower) is seen. The GH cell
adenoma has a diffuse pattern and the null cell
adenoma has a papillary pattern. The nuclei
of GH cell adenoma cells are larger than that
of null cell adenoma. HE stain, x 100. B:
Immunostaining makes the border (orrows)
more distinct. Immunostain for GH, x 200.
the pancreatic tumor showed GHRH but not GH.
His postoperative course was uneventful, and both
plasma GHRH and GH levels decreased to the nor-
mal range. However, plasma GH level increased
again (Fig. l). Magnetic resonance (MR) imaging re-
vealed an increase in the pituitary mass over the past
4 years (Fig. 2). The pituitary adenoma was success-
fully resected by the trans-sphenoidal approach in
November 1992. The postoperative course was un-
eventful. The pituitary adenoma had disappeared on
the postoperative MR image, and his plasma GH lev-
e[ returned to the normal range.
Histological examination of the pituitary adenoma
specimen showed GH cell adenoma and null cell ade-
noma (Fig. 3A). Immunohistochemical staining
showed the GH cell adenoma was positive for GH
(Fig. 38) with a perinuclear pattern of cytokeratin
distribution (densely granulated type). The null cell
adenoma was only positive for cr subunit (Table 1).
Case 2: A 39-year-old male was admitted to our
department with complaints of headache, general fa-
tigue, and decreased libido. Neurological examina-
tion revealed no abnormal findings including in the
visual fields. MR imaging showed a pituitary mass
with suprasellar extension compressing the optic
chiasm. A cystic cavity was also observed in the
center of the adenoma, but no indications of two
different types of adenoma were seen. Preoperative
hormonal loading testing using the four hypothalam-
pituitary adenoma excision
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Fig. 4 Case 2. Photomicrographs of the pituitary
adenoma specimen showing positive GH im-
munostaining of part of the GH cell adenoma(A: x 200), and FSH immunostaining of part
of the gonadotroph adenoma (B: x 200).
ic releasing hormones (GHRH, thyrotropin-releasing
hormone, corticotropin-releasing factor, and luteiniz-
ing hormone ILH]-releasing hormone) disclosed
almost normal anterior pituitary function except for
mildly decreased gonadotropic hormones. This clini-
cally non-functioning pituitary adenoma was resect-
ed through the trans-sphenoidal approach. No signs
of different adenoma types were distinguished during
the operation. The postoperative course was unevent-
ful, and postoperative MR imaging disclosed total
removal of the pituitary adenoma.
Histological examination revealed two different
types of pituitary adenomas in different tissue frag-
ments: GH cell adenoma which had an alveolar pat-
tern, and gonadotroph adenoma with a papillary pat-
tern (Fig. 4). The border of the two adenomas was
not identified.
Discussion
Almost all pituitary adenomas can be divided into
three groups: the GH-prolactin (PRl)-thyroid-
stimulating hormone (TSH) group, the adrenocor-
ticotropic hormone (ACTH) group, and the follicle-
stimulating hormone (FSH)-LH group.15) Each
group contains functioning and non-functioning
adenomas. Therefore, double pituitary adenoma
combinations can be divided into three patterns:
GH-PRL-TSH + FSH-LH groups, GH-PRL-TSH
+ ACTH groups, and ACTH + FSH-LH groups.
These combinations include all 16 reported cases of
double adenomas including ours'o're)and 20 immuno-
histochemicalty proven autopsy cases.e) The GH-
PRL-TSH + FSH-LH groups were most frequent,
accounting for seven of 16 surgical cases and nine of
20 autopsy cases. Both our cases had this common
pattern.
The possible pathogenesis of double or multiple
pituitary adenomas is as followsr0): concurrence of
two independent tumors, distinctly separate with no
causal link; partial transformation of one adenoma
type to another with different histochemical, im-
munocytological, and/ or ultrastructural characteris-
tics; or induction of a second adenoma with different
biological and histological features by some exces-
sive stimulation.
MEN type I is an autosomal dominant disease
caused by a chromosome 11 (llql3) tumor suppres-
sor gene deficiency.r'20) Patients with MEN type I
present with hyperparathyroidism, pancreatic endo-
crine tumors, and pituitary adenomas. Pituitary ade-
nomas occur in about 600/o of patients with MEN
type 1.20) In addition, most of these pituitary adeno-
mas are macroadenomas producing GH or PRL. The
possible mechanism of double pituitary adenoma in
our Case I may have been GH cell hyperplasia and
secondary GH adenoma formation associated with a
pre-existing non-functioning adenoma based on the
preceding GHRH overstimulation. Multiple pitui-
tary adenomas have not been reported associated
with MEN type l, although multiple pancreatic tu-
mors associated with MEN type 1 occur some-
times.2o) More extensive histological examination of
patients with MEN type I may identify more cases
of multiple pituitary adenomas.
Our Case 2 had no genetic background such as
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MEN type l. However, the same combination of
GH-PRL-TSH and FSH-LH groups was seen. There-
fore, the possibility of cooccurring independent
tumors with no causal link was suspected.
Our present cases show that careful histological di-
agnosis of fragmented adenoma tissues is required to
exclude the possibility of double pituitary adenomas
within the same pituitary gland.
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